Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb9c6b40161bafe7bd55f0b4defcea04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df286bcf3a18599522bc7b33bb53cb37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2694cd4e5f0ef715ed4a8c8e274c6395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c6537aa17727ecad099be4ce9c831a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29b24be1a4409fa56f022e786b49c4f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88d3b87006bd7c7e36af63cc43b1efdc |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-033 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1079 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02 |
filingDate |
2008-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_013459a76eb56a893d640c154f4bcdb7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06482abb5379e60d43de61ea9337bd16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0460605f9599bbb7dac9b27fa76fe176 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68952e25cdb229bcd35b0a95eefb55e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4e0781dc0fc55fb41656c60208cb7d2 |
publicationDate |
2012-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8178317-B2 |
titleOfInvention |
Compositions and methods for identifying transforming and tumor suppressor genes |
abstract |
Provided herein are nucleic acids, proteins, vectors, cells, kits, devices and methods useful for identifying regulatable proteins that are able to complement components of cellular signaling pathways. Also provided are compositions and methods using these complementing genes directly as markers for cancer diagnosis or prognosis and as targets for anti-neoplastic therapeutics. Further provided are methods for using changes caused by expression of the complementing genes to indirectly identify associated genes to be used as markers for cancer diagnosis or prognosis and as targets for anti-neoplastic therapeutics. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9820722-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10736615-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11364020-B2 |
priorityDate |
2007-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |